PPARGC1A and diabetic kidney disease: The declined NAD+ levels in DKD, as shown by ours and other (12) in STZ-induced diabetic C57 mice, might lead to disturbed maintenance of mitochondrial function and acetylation of transcriptional factors like PGC-1α by suppressed SIRT activity (34), resulting in renal impairment.